BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated October 29, 2021, titled "Balaxi Pharmaceuticals reports 19% PAT growth YoY for Q2FY22, lays down strategy of backward integration to have a sustainable growth in frontiermarkets".